Home > About > Research Institute

Learn More About Our Current Studies

Interested in participating in a clinical trial? Learn more: 502.368.0732

Family Allergy & Asthma Research Institute has been conducting clinical research since 1991. Our Research Institute is located in our Goss Avenue location. We are continually recognized for our excellence within the research field. Our site has state-of-the-art technology, a computerized database of more than 15,000 patients and we collaborate with most of the national pharmaceutical and clinical research organizations.

We have participated in the clinical trials of allergy medications such as Zyrtec, Allegra, Claritin, Flonase, Nasonex, and many others.

All of our studies are closely monitored by the FDA (Food and Drug Administration) and both regional and national Institutional Review Boards to ensure the rights and safety of all who participate.

Why Participate in Research?

People participate in clinical research for a variety of reasons. We have been told by some of our participants that it gives them a feeling of contributing to the welfare of patients with similar conditions, that they get personalized care with close monitoring of health conditions, and that they have an opportunity to learn more about their condition. Additionally, patients participate because they may be eligible for study-related office visits, physician exams, testing, access to medications, as well as reimbursement for time and travel.

  • ALK PT-03 (PEANUT ALLERGY)

    • The purpose of the study is to investigate at which dose to start, and how to safely raise the dose of a peanut allergy drug in adults, teenagers, and children with peanut allergy.

  • OCTOPHARMA NORM-01 (PID)

    • The study will assess the efficacy of Newnorm in preventing serious bacterial infections in patients with Primary Immunodeficiency.

  • SANOFI- ATLAS (LUNG FUNCTION DECLINE) ADULT AT LEAST 18 YEARS OLD.

    • The primary objective of the study is to assess the effect of Dupilumab on preventing or slowing the rate of lung function decline.

  • GSK (SALBUTAMOL) ≥ 18 YEARS OF AGE

    •  The purpose of the study is to assess and compare safety and tolerability of 3 months treatment with salbutamol administered via MDI containing propellant HFA-152a or HFA‑134a in participants ≥ 18 years of age with asthma.

  • ASTRAZENECA (PROPELLANT) ≥ 18 YEARS OF AGE

    • This study will assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant, HFO, compared with BDA delivered using the currently approved propellant, HFA, in participants with asthma.

  • REGENERON (AIM4) ADULTS AND ADOLESCENTS 12-80 YEARS OF AGE

    •  The purpose of the study is to evaluate the efficacy of dupilumab added to medium dose ICS/LABA in reducing severe asthma exacerbations in comparison to ICS dose escalation to high dose ICS-LABA in participants with uncontrolled asthma.

  • ASTRAZENECA (FLASH) ≥ 18 YEARS OF AGE

    •  The purpose of this study is to assess the efficacy and safety of Multiple dose levels of Atuliflapon Given Orally Once Daily for twelve Weeks in Adults with Moderate to Severe Uncontrolled Asthma.

  • AMGEN (ROCATINLIMAB) 18 – 75 YEARS OF AGE

    • The purpose of the study is to describe the efficacy Rocatinlimab in reducing exacerbations.
Learn More About Our Current Studies

Interested in hearing more about these Research Trials?

Please contact one of our staff at 502.368.0732 or fill out the form below:

  • This field is for validation purposes and should be left unchanged.

About Family Allergy & Asthma Research Institute Team

Our research is fueled by a shared goal to enhance lives through evidence-based findings and innovations. Whether through clinical trials or collaborative discussions, our team remains committed to advancing care.

Principal Investigator & Medical Director

J. Wesley Sublett, MD Headshot

James Wesley Sublett, MD

Clinical Research Coordinators

Becky Whitehead, RN/CCRC
Director of Clinical Research

Amber Noe, LPN/CCRC
Danielle Warren, RN/CRC

Sub-Investigators

Stephen J. Pollard, MD
James L. Sublett, MD
Thomas Glass, MD
Nathan Richards, MD
Angela Soltero, APRN
Vanessa Magee, APRN
Lesley White, APRN

Address:

Family Allergy & Asthma Research Institute
1261 Goss Avenue
Louisville, KY 40217

Phone: 502.368.0732

Fax: 502.470.9994

Home > About > Research Institute